Literature DB >> 10560684

Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic.

L Peruzzi, B Gianoglio, M G Porcellini, R Coppo.   

Abstract

Cyclo-oxygenase-type-2 (COX-2) enzyme is fundamental for nephrogenesis, upregulated on fetal membranes and myometrium at parturition. Fetal COX-2 inhibition, due to maternal nimesulide assumption, can be responsible for neonatal chronic renal failure.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10560684     DOI： 10.1016/S0140-6736(99)03105-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  14 in total

1.  Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study.

Authors:  L Cataldi; R Leone; U Moretti; B De Mitri; V Fanos; L Ruggeri; G Sabatino; F Torcasio; V Zanardo; G Attardo; F Riccobene; C Martano; D Benini; L Cuzzolin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-11       Impact factor: 5.747

2.  Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions.

Authors:  Laura Cuzzolin; Vassilios Fanos; Bernadette Pinna; Maria di Marzio; Monica Perin; Paola Tramontozzi; Paola Tonetto; Luigi Cataldi
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

3.  Renal tubular dysgenesis associated with in utero exposure to Nimuselide.

Authors:  Uma Sankari Ali; Sheila Khubchandani; Parmanand Andankar; Shashank Parekhji; Vishal Dubhalish; Bhavna Padhye
Journal:  Pediatr Nephrol       Date:  2005-12-03       Impact factor: 3.714

Review 4.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Risk factors associated with acute kidney injury in extremely low birth weight (ELBW) infants.

Authors:  Sreekanth Viswanathan; Bindu Manyam; Timur Azhibekov; Maroun J Mhanna
Journal:  Pediatr Nephrol       Date:  2011-08-03       Impact factor: 3.714

6.  Maternal ingestion of diclofenac leading to renal failure in newborns.

Authors:  Varsha Phadke; Swati Bhardwaj; Bandya Sahoo; Sujata Kanhere
Journal:  Pediatr Nephrol       Date:  2012-02-14       Impact factor: 3.714

7.  Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse.

Authors:  J Reese; B C Paria; N Brown; X Zhao; J D Morrow; S K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 8.  New perspectives in treatment of glomerulonephritis.

Authors:  Rosanna Coppo; Alessandro Amore
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

9.  Evaluating and managing neonatal acute renal failure in a resource-poor setting.

Authors:  Tinuade A Ogunlesi; Folasade Adekanmbi
Journal:  Indian J Pediatr       Date:  2009-04-06       Impact factor: 1.967

10.  The adverse renal effects of prostaglandin-synthesis inhibition in the fetus and the newborn.

Authors:  Alfred Drukker
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.